• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Port Info

• Ships in Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• The Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Chennai , Aug. 25

THE Chennai-based Grandix Pharmaceuticals Ltd has tied up with Chromogenix, Italy - a group company of one of the world's largest diagnostics major Instrumentation Laboratory Inc - to market chromegenic substrates in India.

Grandix will market chromogenic substrates with a portfolio of more than 70 products in the field of coagulation and fibrinolysis throughout India. Chromegenic substrates is used widely in pharma and R&D labs, biotechnology companies, blood banks, clinical laboratories and hospitals.

"We are the first company to import and start supplying chromogenic substrates in India," Dr A. Ramamurthy, Managing Director, Grandix Pharmaceuticals Ltd, has said in a press release. "Earlier R & D labs used to import chromogenic substrates which were procured after a long wait."

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Glenmark's asthma drug gets nod for further trials

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line